Nexalin Technology, Inc. (NXL)
NXL Stock Price Chart
Explore Nexalin Technology, Inc. interactive price chart. Choose custom timeframes to analyze NXL price movements and trends.
NXL Company Profile
Discover essential business fundamentals and corporate details for Nexalin Technology, Inc. (NXL) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
16 Sept 2022
Employees
6.00
Website
https://www.nexalin.comCEO
Mark White
Description
Nexalin Technology, Inc. operates as a medical device firm specializing in the creation and advancement of neurostimulation therapies for mental health conditions in both the United States and China. The company commercializes its primary product, the Nexalin Device, which provides a non-invasive and drug-free treatment for anxiety and insomnia. This device functions by emitting a proprietary frequency-based waveform designed to elicit a beneficial response from mid-brain structures associated with various psychological disorders. Furthermore, Nexalin Technology is currently developing "Generation 2," a new medical device undergoing clinical trials. This future product aims to address a broader spectrum of health issues, including opiate addiction, persistent pain, Alzheimer's disease, and dementia. The company was founded in 2021 and has its headquarters in Houston, Texas.
NXL Financial Timeline
Browse a chronological timeline of Nexalin Technology, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 2 Sept 2026
EPS estimate is -$0.10, while revenue estimate is $90.00k.
Earnings released on 8 May 2026
EPS came in at -$0.11 matching the estimated -$0.11, while revenue for the quarter reached $15.00k , meeting expectations.
Earnings released on 25 Mar 2026
EPS came in at -$0.13 falling short of the estimated -$0.12 by -8.33%, while revenue for the quarter reached $172.00k , beating expectations by +115.00%.
Earnings released on 14 Nov 2025
EPS came in at -$0.13 falling short of the estimated -$0.12 by -8.33%, while revenue for the quarter reached $18.15k , missing expectations by -54.63%.
Earnings released on 6 Aug 2025
EPS came in at -$0.10 matching the estimated -$0.10, while revenue for the quarter reached $70.59k , missing expectations by -0.58%.
Earnings released on 13 May 2025
EPS came in at -$0.15 falling short of the estimated -$0.10 by -50.00%, while revenue for the quarter reached $41.02k , beating expectations by +0.04%.
Earnings released on 14 Mar 2025
EPS came in at -$0.28 falling short of the estimated -$0.12 by -133.33%, while revenue for the quarter reached $27.18k , missing expectations by -9.40%.
Earnings released on 8 Nov 2024
EPS came in at -$0.23 falling short of the estimated -$0.12 by -91.67%, while revenue for the quarter reached $36.03k , beating expectations by +20.10%.
Earnings released on 8 Aug 2024
EPS came in at -$0.17 , while revenue for the quarter reached $26.84k .
Earnings released on 10 May 2024
EPS came in at -$0.14 , while revenue for the quarter reached $78.67k .
Earnings released on 27 Mar 2024
EPS came in at -$0.10 , while revenue for the quarter reached $20.54k .
Earnings released on 13 Nov 2023
EPS came in at -$0.31 , while revenue for the quarter reached $24.11k .
Earnings released on 10 Aug 2023
EPS came in at -$0.11 , while revenue for the quarter reached $35.54k .
Earnings released on 10 May 2023
EPS came in at -$0.10 , while revenue for the quarter reached $30.56k .
Earnings released on 27 Mar 2023
EPS came in at -$0.11 , while revenue for the quarter reached $38.42k .
Earnings released on 2 Mar 2023
EPS came in at -$0.03 , while revenue for the quarter reached $545.32k .
Earnings released on 30 Jun 2022
EPS came in at -$0.07 , while revenue for the quarter reached $414.29k .
Earnings released on 31 Mar 2022
EPS came in at -$0.06 , while revenue for the quarter reached $323.32k .
Earnings released on 31 Dec 2021
EPS came in at -$0.13 , while revenue for the quarter reached $24.00k .
Earnings released on 30 Sept 2021
EPS came in at -$0.37 , while revenue for the quarter reached $55.97k .
NXL Stock Performance
Access detailed NXL performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
